Bayesian Methods for Quality Tolerance Limit (<scp>QTL</scp>) Monitoring

In alignment with the ICH guideline for Good Clinical Practice [ICH E6(R2)], quality tolerance limit (QTL) monitoring has become a standard component of risk-based monitoring of clinical trials by sponsor companies. Parameters that are candidates for QTL monitoring are critical to participant safety and quality of trial results. Breaching the QTL of a given parameter could indicate systematic issues with the trial that could impact participant safety or compromise the reliability of trial results. Methods for QTL monitoring should detect potential QTL breaches as early as possible while limiting the rate of false alarms. Early detection allows for the implementation of remedial actions that can prevent a QTL breach at the end of the trial. We demonstrate that statistically based methods that account for the expected value and variability of the data generating process outperform simple methods based on fixed thresholds with respect to important operating characteristics. We also propose a Bayesian method for QTL monitoring and an extension that allows for the incorporation of partial information, demonstrating its potential to outperform frequentist methods originating from the statistical process control literature.

Authors

Institutions

Publication Details

Journal
Pharmaceutical Statistics
Published
2024-08-09
DOI
https://doi.org/10.1002/pst.2427
Citations
5
Primary Topic
Statistical Methods in Clinical Trials
Type
article
Field-Weighted Citation Impact
3.55
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Bayesian Methods for Quality Tolerance Limit (QTL) Monitoring

Jun S. Liu, J. C. Poythress, Jin Hyung Lee, Kentaro Takeda
5 citations
Pharmaceutical Statistics
Statistical Methods in Clinical Trials
3.55
article

Bayesian Methods for Quality Tolerance Limit (QTL) Monitoring

Jun S. Liu, J. C. Poythress, Jin Hyung Lee, Kentaro Takeda
article en
5 citations

Abstract

In alignment with the ICH guideline for Good Clinical Practice [ICH E6(R2)], quality tolerance limit (QTL) monitoring has become a standard component of risk-based monitoring of clinical trials by sponsor companies. Parameters that are candidates for QTL monitoring are critical to participant safety and quality of trial results. Breaching the QTL of a given parameter could indicate systematic issues with the trial that could impact participant safety or compromise the reliability of trial results. Methods for QTL monitoring should detect potential QTL breaches as early as possible while limiting the rate of false alarms. Early detection allows for the implementation of remedial actions that can prevent a QTL breach at the end of the trial. We demonstrate that statistically based methods that account for the expected value and variability of the data generating process outperform simple methods based on fixed thresholds with respect to important operating characteristics. We also propose a Bayesian method for QTL monitoring and an extension that allows for the incorporation of partial information, demonstrating its potential to outperform frequentist methods originating from the statistical process control literature.

Pharmaceutical StatisticsVol. 23(6)
George Mason University (US), Astellas Pharma (United States) (US)
Openalex Percentile: Top 7%
Statistical Methods in Clinical Trials
3.55
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.